C
CGON icon

Covestor’s CG Oncology CGON Stock Holding History

Covestor’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32K Buy
446
+132
+42% +$8.63K 0.02% 989
2026
Q1 		$21K Sell
314
-35
-10% -$1.98K 0.01% 1080
2025
Q4 		$14K Sell
349
-116
-25% -$4.8K 0.01% 1424
2025
Q3 		$19K Sell
465
-4
-0.9% -$116 0.01% 1282
2025
Q2 		$12K Buy
469
+465
+11,625% +$11.2K 0.01% 1455
2025
Q1 		$0 Hold
4
– – ﹤0.01% 2270
2024
Q4 		$0 Hold
4
– – ﹤0.01% 2278
2024
Q3 		$0 Hold
4
– – ﹤0.01% 2266
2024
Q2 		$0 Buy
+4
New +$139 ﹤0.01% 2276

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Covestor's CGON Position: Q2 2026 in Review

Covestor increased its CG Oncology (CGON) stake by 42% in Q2 2026, buying an estimated $8.63K and bringing the position to 446 shares worth $32K. The position accounts for 0.02% of the portfolio, ranked #989.

Covestor first reported a position in CGON in Q2 2024 and has held it in 9 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Covestor held 446 shares of CG Oncology worth $32K as of Q2 2026.
  • Covestor bought 132 CG Oncology shares in Q2 2026, an estimated $8.63K.
  • CG Oncology made up 0.02% of Covestor's portfolio in Q2 2026, its #989 holding.
  • Covestor first reported a position in CG Oncology in Q2 2024 and has held it in 9 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.